A citation-based method for searching scientific literature

Matthew R Weir, Andrzej Januszewicz, Richard E Gilbert, Ujjwala Vijapurkar, Irina Kline, Albert Fung, Gary Meininger. J Clin Hypertens (Greenwich) 2014
Times Cited: 65



Keith Usiskin, Irina Kline, Albert Fung, Cristiana Mayer, Gary Meininger. Postgrad Med 2014
Times Cited: 74




List of shared articles



Times cited

Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials.
Lawrence Blonde, Vincent Woo, Chantal Mathieu, Jacqueline Yee, Ujjwala Vijapurkar, William Canovatchel, Gary Meininger. Curr Med Res Opin 2015
7

Achieving the composite endpoint of HbA1c, body weight, and systolic blood pressure reduction with canagliflozin in patients with type 2 diabetes.
Katherine Merton, Michael J Davies, Ujjwala Vijapurkar, Doreen Inman, Gary Meininger. Curr Med Res Opin 2018
4


A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus.
K M Prasanna Kumar, Sujoy Ghosh, William Canovatchel, Nishant Garodia, Sujith Rajashekar. Indian J Endocrinol Metab 2017
7

Response to Stavropoulos.
Raymond R Townsend, Israel Machin, Jimmy Ren, Angelina Trujillo, Masato Kawaguchi, Ujjwala Vijapurkar, C V Damaraju, Michael Pfeifer. J Clin Hypertens (Greenwich) 2016
0

Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2.
Srikanth Yandrapalli, Aaqib Malik, Adam Horblitt, Gayatri Pemmasani, Wilbert S Aronow, William H Frishman. Cardiol Rev 2020
2


Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Norm Rosenthal, Gary Meininger, Kirk Ways, David Polidori, Mehul Desai, Rong Qiu, Maria Alba, Frank Vercruysse, Dainius Balis, Wayne Shaw,[...]. Ann N Y Acad Sci 2015
61





Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis.
Rong Qiu, Dainius Balis, John Xie, Michael J Davies, Mehul Desai, Gary Meininger. Curr Med Res Opin 2017
20




Canagliflozin: A Review in Type 2 Diabetes.
Emma D Deeks, André J Scheen. Drugs 2017
17